Status:
UNKNOWN
Prediction of Lupus Renal Flares Study
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Systemic Lupus Erythematosus
Eligibility:
All Genders
18-99 years
Brief Summary
In patients with systemic lupus erythematosus, urinary CD4+ T cells may have the potential to predict subsequent renal flares in the next 6 months. Patients with systemic lupus erythematosus from our ...
Eligibility Criteria
Inclusion
- Informed consent
- Diagnosis of SLE according to the 2019 EULAR/ACR classification criteria Stable immunosuppressive or biologic background therapy within the last 6 months prior to inclusion
Exclusion
- Age \< 18
- Inability to consent
- Urinary tract infection (defined by detection of nitrite or positive urine culture)
- Patients on chronic dialysis
- Concomitant other autoimmune disease
Key Trial Info
Start Date :
February 28 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05362812
Start Date
February 28 2022
End Date
April 1 2023
Last Update
May 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nephrology and Intensive Care, Charite University Hospital
Berlin, Germany, 10117